Basilea Pharmaceutica
Basilea Pharmaceutica
Explore linked clinical trials.5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects | Healthy | Recruiting | Phase 1 | 2026-09-14 | NCT07500181 | |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections. | Bacterial Infections and Mycoses, Infections, fungal infectious disease | Recruiting | Phase 3 | 2026-09-14 | NCT06925321 | |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. | Bacterial Infections and Mycoses, Fungemia, Infections, Inflammation, Invasive Fungal Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, Torulopsis, candidemia, candidiasis, candidiasis, invasive, fungal infectious disease | Recruiting | Phase 3 | 2026-09-14 | NCT05421858 | |
| Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination | Drug-Drug Interaction (DDI); FDC; Healthy Volunteer; Pharmacokinetics; Safety | Recruiting | Phase 1 | 2026-07-09 | NCT06733675 | |
| FungiScope - A Global Emerging Fungal Infection Registry | Bacterial Infections and Mycoses, Infections, Invasive Fungal Infections, fungal infectious disease | Recruiting | Not stated | 2023-12-05 | NCT01731353 |